The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Galectin Therapeutics Inc shares valued at $1,300 were purchased by ELDRED KARY on Oct 23 ’24. At $2.60 per share, ELDRED KARY acquired 500 shares. The insider’s holdings grew to 50,213 shares worth approximately $0.1 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, FREEMAN KEVIN D purchased 1,300 shares, netting a total of over 3,432 in proceeds. Following the buying of shares at $2.64 each, the insider now holds 34,769 shares.
Before that, FREEMAN KEVIN D had added 5,000 shares to its account. In a trade valued at $13,500, the Director bought Galectin Therapeutics Inc shares for $2.70 each. Upon closing the transaction, the insider’s holdings increased to 5,000 shares, worth approximately $0.16 million.
As published in a research note from H.C. Wainwright on August 13, 2020, Galectin Therapeutics Inc [GALT] has been retained to a Buy and the price target has been revised to $12. Analysts at B. Riley FBR started covering the stock with ‘”a Buy”‘ outlook in a report released in mid February. As of December 07, 2017, H.C. Wainwright has reiterated its “Buy” rating for GALT. Earlier on November 28, 2017, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for GALT stock.
Analyzing GALT Stock Performance
During the last five days, there has been a surge of approximately 3.59%. Over the course of the year, Galectin Therapeutics Inc shares have jumped approximately 21.69%. Shares of the company reached a 52-week high of $4.27 on 04/12/24 and a 52-week low of $1.59 on 02/07/24. A 50-day SMA is recorded $2.56, while a 200-day SMA reached $2.65. Nevertheless, trading volume fell to 0.87 million shares from 0.92 million shares the previous day.
Support And Resistance Levels for Galectin Therapeutics Inc (GALT)
According to the 24-hour chart, there is a support level at 1.94, which, if violated, would cause prices to drop to 1.87. In the upper region, resistance lies at 2.12. The next price resistance is at 2.23. RSI (Relative Strength Index) is 37.11 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.07, which suggests the price will decrease in the coming days. Percent R is at 80.69%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
